Skip to main content

Advertisement

Fig. 2 | Clinical and Translational Allergy

Fig. 2

From: Does clinical outcome of birch pollen immunotherapy relate to induction of blocking antibodies preventing IgE from allergen binding? A pilot study monitoring responses during first year of AIT

Fig. 2

Reactivity of different antibody subclasses against birch pollen proteins and therapy-related changes. Immunoblot experiments with birch pollen extract and sera of birch pollen AIT patients (P1–5) collected at three time points of immunotherapy (T0, T1, and T2). Bet v 1 is framed in black; NA, non-allergic serum; NBA, non-birch allergic serum; BC, buffer control

Back to article page